← All trials
NCT03537768
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 12, 2018
- Primary completion
- Aug 1, 2019
- Completion date
- Aug 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 1200
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Health DecisionsLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Institute of Child Health and Human Development (NICHD)Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.